<DOC>
	<DOCNO>NCT00415792</DOCNO>
	<brief_summary>hCG GnRH agonist use induce final oocyte maturation ovulation IVF cycle . These two approach compare study term pregnancy rate embryological data use patient hyper-response IVF drug .</brief_summary>
	<brief_title>Comparison Between hCG GnRH Agonist Ovulation Induction Patients With High Response IVF Drugs</brief_title>
	<detailed_description>hCG commonly use substitution endogenous LH surge induce oocyte maturation ovulation induction ovarian hyperstimulation protocol vitro fertilization ( IVF ) . However , hCG related occurrence ovarian hyperstimulation syndrome ( OHSS ) , potentially life-threatening complication hyper-responding patient particularly high risk . An alternative exogenous hCG administration GnRH agonist induce endogenous rise LH FSH level due initial flare effect . Comparisons : Pregnancy rate embryological data compare hyper-responding patient receive either GnRH agonist ( Arvekap ) hCG ( Pregnyl ) ovulatrion induction follow GnRH antagonist treatment cycle .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Hyperresponder patient ( &gt; 20 oocyte retrieve ) Normal responder Poor responder PCOS</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Ovulation induction</keyword>
	<keyword>hCG</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>hyper-responders</keyword>
</DOC>